Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000713913 | SCV000844557 | pathogenic | not provided | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001382877 | SCV001581832 | pathogenic | Tuberous sclerosis 2 | 2022-08-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 49656). This premature translational stop signal has been observed in individual(s) with tuberous sclerosis (PMID: 16981987). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Gln354*) in the TSC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TSC2 are known to be pathogenic (PMID: 10205261, 17304050). |
Genome- |
RCV001382877 | SCV002040927 | pathogenic | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000042918 | SCV000066714 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |